Global Biliary Tumor Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 310637
  • calendar_today Published On: Jun, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Biliary Tumor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Biliary Tumor market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Biliary Tumor global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Mecine segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Biliary Tumor include NuCana, NeoGenomics, Novartis, GlaxoSmithKline, and Southwest Oncology Group, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Biliary Tumor market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Mecine

Surgery

Other

Market segment by Application, can be divided into

Hospitals

Clinics

Other

Market segment by players, this report covers

NuCana

NeoGenomics

Novartis

GlaxoSmithKline

Southwest Oncology Group

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Biliary Tumor product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Biliary Tumor, with revenue, gross margin and global market share of Biliary Tumor from 2019 to 2022.

Chapter 3, the Biliary Tumor competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biliary Tumor market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Biliary Tumor research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Biliary Tumor

1.2 Classification of Biliary Tumor by Type

1.2.1 Overview: Global Biliary Tumor Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Biliary Tumor Revenue Market Share by Type in 2021

1.2.3 Mecine

1.2.4 Surgery

1.2.5 Other

1.3 Global Biliary Tumor Market by Application

1.3.1 Overview: Global Biliary Tumor Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Global Biliary Tumor Market Size & Forecast

1.5 Global Biliary Tumor Market Size and Forecast by Region

1.5.1 Global Biliary Tumor Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Biliary Tumor Market Size by Region, (2017-2022)

1.5.3 North America Biliary Tumor Market Size and Prospect (2017-2028)

1.5.4 Europe Biliary Tumor Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Biliary Tumor Market Size and Prospect (2017-2028)

1.5.6 South America Biliary Tumor Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Biliary Tumor Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Biliary Tumor Market Drivers

1.6.2 Biliary Tumor Market Restraints

1.6.3 Biliary Tumor Trends Analysis

2 Company Profiles

2.1 NuCana

2.1.1 NuCana Details

2.1.2 NuCana Major Business

2.1.3 NuCana Biliary Tumor Product and Solutions

2.1.4 NuCana Biliary Tumor Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 NuCana Recent Developments and Future Plans

2.2 NeoGenomics

2.2.1 NeoGenomics Details

2.2.2 NeoGenomics Major Business

2.2.3 NeoGenomics Biliary Tumor Product and Solutions

2.2.4 NeoGenomics Biliary Tumor Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 NeoGenomics Recent Developments and Future Plans

2.3 Novartis

2.3.1 Novartis Details

2.3.2 Novartis Major Business

2.3.3 Novartis Biliary Tumor Product and Solutions

2.3.4 Novartis Biliary Tumor Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Novartis Recent Developments and Future Plans

2.4 GlaxoSmithKline

2.4.1 GlaxoSmithKline Details

2.4.2 GlaxoSmithKline Major Business

2.4.3 GlaxoSmithKline Biliary Tumor Product and Solutions

2.4.4 GlaxoSmithKline Biliary Tumor Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 GlaxoSmithKline Recent Developments and Future Plans

2.5 Southwest Oncology Group

2.5.1 Southwest Oncology Group Details

2.5.2 Southwest Oncology Group Major Business

2.5.3 Southwest Oncology Group Biliary Tumor Product and Solutions

2.5.4 Southwest Oncology Group Biliary Tumor Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Southwest Oncology Group Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Biliary Tumor Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Biliary Tumor Players Market Share in 2021

3.2.2 Top 10 Biliary Tumor Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Biliary Tumor Players Head Office, Products and Services Provided

3.4 Biliary Tumor Mergers & Acquisitions

3.5 Biliary Tumor New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Biliary Tumor Revenue and Market Share by Type (2017-2022)

4.2 Global Biliary Tumor Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Biliary Tumor Revenue Market Share by Application (2017-2022)

5.2 Global Biliary Tumor Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Biliary Tumor Revenue by Type (2017-2028)

6.2 North America Biliary Tumor Revenue by Application (2017-2028)

6.3 North America Biliary Tumor Market Size by Country

6.3.1 North America Biliary Tumor Revenue by Country (2017-2028)

6.3.2 United States Biliary Tumor Market Size and Forecast (2017-2028)

6.3.3 Canada Biliary Tumor Market Size and Forecast (2017-2028)

6.3.4 Mexico Biliary Tumor Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Biliary Tumor Revenue by Type (2017-2028)

7.2 Europe Biliary Tumor Revenue by Application (2017-2028)

7.3 Europe Biliary Tumor Market Size by Country

7.3.1 Europe Biliary Tumor Revenue by Country (2017-2028)

7.3.2 Germany Biliary Tumor Market Size and Forecast (2017-2028)

7.3.3 France Biliary Tumor Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Biliary Tumor Market Size and Forecast (2017-2028)

7.3.5 Russia Biliary Tumor Market Size and Forecast (2017-2028)

7.3.6 Italy Biliary Tumor Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Biliary Tumor Revenue by Type (2017-2028)

8.2 Asia-Pacific Biliary Tumor Revenue by Application (2017-2028)

8.3 Asia-Pacific Biliary Tumor Market Size by Region

8.3.1 Asia-Pacific Biliary Tumor Revenue by Region (2017-2028)

8.3.2 China Biliary Tumor Market Size and Forecast (2017-2028)

8.3.3 Japan Biliary Tumor Market Size and Forecast (2017-2028)

8.3.4 South Korea Biliary Tumor Market Size and Forecast (2017-2028)

8.3.5 India Biliary Tumor Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Biliary Tumor Market Size and Forecast (2017-2028)

8.3.7 Australia Biliary Tumor Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Biliary Tumor Revenue by Type (2017-2028)

9.2 South America Biliary Tumor Revenue by Application (2017-2028)

9.3 South America Biliary Tumor Market Size by Country

9.3.1 South America Biliary Tumor Revenue by Country (2017-2028)

9.3.2 Brazil Biliary Tumor Market Size and Forecast (2017-2028)

9.3.3 Argentina Biliary Tumor Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Biliary Tumor Revenue by Type (2017-2028)

10.2 Middle East & Africa Biliary Tumor Revenue by Application (2017-2028)

10.3 Middle East & Africa Biliary Tumor Market Size by Country

10.3.1 Middle East & Africa Biliary Tumor Revenue by Country (2017-2028)

10.3.2 Turkey Biliary Tumor Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Biliary Tumor Market Size and Forecast (2017-2028)

10.3.4 UAE Biliary Tumor Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Biliary Tumor Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Biliary Tumor Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Biliary Tumor Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Biliary Tumor Revenue (USD Million) by Region (2017-2022)

Table 5. Global Biliary Tumor Revenue Market Share by Region (2023-2028)

Table 6. NuCana Corporate Information, Head Office, and Major Competitors

Table 7. NuCana Major Business

Table 8. NuCana Biliary Tumor Product and Solutions

Table 9. NuCana Biliary Tumor Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. NeoGenomics Corporate Information, Head Office, and Major Competitors

Table 11. NeoGenomics Major Business

Table 12. NeoGenomics Biliary Tumor Product and Solutions

Table 13. NeoGenomics Biliary Tumor Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Novartis Corporate Information, Head Office, and Major Competitors

Table 15. Novartis Major Business

Table 16. Novartis Biliary Tumor Product and Solutions

Table 17. Novartis Biliary Tumor Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 19. GlaxoSmithKline Major Business

Table 20. GlaxoSmithKline Biliary Tumor Product and Solutions

Table 21. GlaxoSmithKline Biliary Tumor Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Southwest Oncology Group Corporate Information, Head Office, and Major Competitors

Table 23. Southwest Oncology Group Major Business

Table 24. Southwest Oncology Group Biliary Tumor Product and Solutions

Table 25. Southwest Oncology Group Biliary Tumor Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Global Biliary Tumor Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 27. Global Biliary Tumor Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 28. Breakdown of Biliary Tumor by Company Type (Tier 1, Tier 2 and Tier 3)

Table 29. Biliary Tumor Players Head Office, Products and Services Provided

Table 30. Biliary Tumor Mergers & Acquisitions in the Past Five Years

Table 31. Biliary Tumor New Entrants and Expansion Plans

Table 32. Global Biliary Tumor Revenue (USD Million) by Type (2017-2022)

Table 33. Global Biliary Tumor Revenue Share by Type (2017-2022)

Table 34. Global Biliary Tumor Revenue Forecast by Type (2023-2028)

Table 35. Global Biliary Tumor Revenue by Application (2017-2022)

Table 36. Global Biliary Tumor Revenue Forecast by Application (2023-2028)

Table 37. North America Biliary Tumor Revenue by Type (2017-2022) & (USD Million)

Table 38. North America Biliary Tumor Revenue by Type (2023-2028) & (USD Million)

Table 39. North America Biliary Tumor Revenue by Application (2017-2022) & (USD Million)

Table 40. North America Biliary Tumor Revenue by Application (2023-2028) & (USD Million)

Table 41. North America Biliary Tumor Revenue by Country (2017-2022) & (USD Million)

Table 42. North America Biliary Tumor Revenue by Country (2023-2028) & (USD Million)

Table 43. Europe Biliary Tumor Revenue by Type (2017-2022) & (USD Million)

Table 44. Europe Biliary Tumor Revenue by Type (2023-2028) & (USD Million)

Table 45. Europe Biliary Tumor Revenue by Application (2017-2022) & (USD Million)

Table 46. Europe Biliary Tumor Revenue by Application (2023-2028) & (USD Million)

Table 47. Europe Biliary Tumor Revenue by Country (2017-2022) & (USD Million)

Table 48. Europe Biliary Tumor Revenue by Country (2023-2028) & (USD Million)

Table 49. Asia-Pacific Biliary Tumor Revenue by Type (2017-2022) & (USD Million)

Table 50. Asia-Pacific Biliary Tumor Revenue by Type (2023-2028) & (USD Million)

Table 51. Asia-Pacific Biliary Tumor Revenue by Application (2017-2022) & (USD Million)

Table 52. Asia-Pacific Biliary Tumor Revenue by Application (2023-2028) & (USD Million)

Table 53. Asia-Pacific Biliary Tumor Revenue by Region (2017-2022) & (USD Million)

Table 54. Asia-Pacific Biliary Tumor Revenue by Region (2023-2028) & (USD Million)

Table 55. South America Biliary Tumor Revenue by Type (2017-2022) & (USD Million)

Table 56. South America Biliary Tumor Revenue by Type (2023-2028) & (USD Million)

Table 57. South America Biliary Tumor Revenue by Application (2017-2022) & (USD Million)

Table 58. South America Biliary Tumor Revenue by Application (2023-2028) & (USD Million)

Table 59. South America Biliary Tumor Revenue by Country (2017-2022) & (USD Million)

Table 60. South America Biliary Tumor Revenue by Country (2023-2028) & (USD Million)

Table 61. Middle East & Africa Biliary Tumor Revenue by Type (2017-2022) & (USD Million)

Table 62. Middle East & Africa Biliary Tumor Revenue by Type (2023-2028) & (USD Million)

Table 63. Middle East & Africa Biliary Tumor Revenue by Application (2017-2022) & (USD Million)

Table 64. Middle East & Africa Biliary Tumor Revenue by Application (2023-2028) & (USD Million)

Table 65. Middle East & Africa Biliary Tumor Revenue by Country (2017-2022) & (USD Million)

Table 66. Middle East & Africa Biliary Tumor Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Biliary Tumor Picture

Figure 2. Global Biliary Tumor Revenue Market Share by Type in 2021

Figure 3. Mecine

Figure 4. Surgery

Figure 5. Other

Figure 6. Biliary Tumor Revenue Market Share by Application in 2021

Figure 7. Hospitals Picture

Figure 8. Clinics Picture

Figure 9. Other Picture

Figure 10. Global Biliary Tumor Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 11. Global Biliary Tumor Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Biliary Tumor Revenue Market Share by Region (2017-2028)

Figure 13. Global Biliary Tumor Revenue Market Share by Region in 2021

Figure 14. North America Biliary Tumor Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Europe Biliary Tumor Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Asia-Pacific Biliary Tumor Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. South America Biliary Tumor Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Middle East and Africa Biliary Tumor Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Biliary Tumor Market Drivers

Figure 20. Biliary Tumor Market Restraints

Figure 21. Biliary Tumor Market Trends

Figure 22. NuCana Recent Developments and Future Plans

Figure 23. NeoGenomics Recent Developments and Future Plans

Figure 24. Novartis Recent Developments and Future Plans

Figure 25. GlaxoSmithKline Recent Developments and Future Plans

Figure 26. Southwest Oncology Group Recent Developments and Future Plans

Figure 27. Global Biliary Tumor Revenue Share by Players in 2021

Figure 28. Biliary Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 29. Global Top 3 Players Biliary Tumor Revenue Market Share in 2021

Figure 30. Global Top 10 Players Biliary Tumor Revenue Market Share in 2021

Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 32. Global Biliary Tumor Revenue Share by Type in 2021

Figure 33. Global Biliary Tumor Market Share Forecast by Type (2023-2028)

Figure 34. Global Biliary Tumor Revenue Share by Application in 2021

Figure 35. Global Biliary Tumor Market Share Forecast by Application (2023-2028)

Figure 36. North America Biliary Tumor Sales Market Share by Type (2017-2028)

Figure 37. North America Biliary Tumor Sales Market Share by Application (2017-2028)

Figure 38. North America Biliary Tumor Revenue Market Share by Country (2017-2028)

Figure 39. United States Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 40. Canada Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 41. Mexico Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Europe Biliary Tumor Sales Market Share by Type (2017-2028)

Figure 43. Europe Biliary Tumor Sales Market Share by Application (2017-2028)

Figure 44. Europe Biliary Tumor Revenue Market Share by Country (2017-2028)

Figure 45. Germany Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. France Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. United Kingdom Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Russia Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Italy Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Asia-Pacific Biliary Tumor Sales Market Share by Type (2017-2028)

Figure 51. Asia-Pacific Biliary Tumor Sales Market Share by Application (2017-2028)

Figure 52. Asia-Pacific Biliary Tumor Revenue Market Share by Region (2017-2028)

Figure 53. China Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Japan Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. South Korea Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. India Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Southeast Asia Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Australia Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. South America Biliary Tumor Sales Market Share by Type (2017-2028)

Figure 60. South America Biliary Tumor Sales Market Share by Application (2017-2028)

Figure 61. South America Biliary Tumor Revenue Market Share by Country (2017-2028)

Figure 62. Brazil Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Argentina Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Middle East and Africa Biliary Tumor Sales Market Share by Type (2017-2028)

Figure 65. Middle East and Africa Biliary Tumor Sales Market Share by Application (2017-2028)

Figure 66. Middle East and Africa Biliary Tumor Revenue Market Share by Country (2017-2028)

Figure 67. Turkey Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Saudi Arabia Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. UAE Biliary Tumor Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Methodology

Figure 71. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz